Technical Articles
PROTAC.
Precisely Driving PROTAC Development: Human BCL6/CRBN Molecular Glue Binding Detection Kit
In the field of targeted protein degradation, particularly in the development of molecular glue drugs targeting the critical transcription factor BCL6, rapidly and accurately quantifying the efficiency of ternary complex formation induced by candidate compounds is a key step to accelerate lead compound discovery and optimization.
View details
- Cancer
- Targeted protein
- BCL6/CRBN
- PROTAC.
- 1












